← Eichor
Condition: Intratumoral Injection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Intratumoral Injection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresecta
Phase 2 · 1 location(s) · Philogen S.p.A. · NCT06284590Intratumoral Injection of Autologous CD1c (BDCA-1)+ MyDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab
Phase 1/Phase 2 · 1 location(s) · Universitair Ziekenhuis Brussel · NCT03707808A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
Phase 1 · 4 location(s) · Kortuc, Inc. · NCT05570422Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
Phase 1/Phase 2 · 1 location(s) · Coordination Pharmaceuticals, Inc. · NCT05838729Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
Phase 1/Phase 2 · 4 location(s) · Guangzhou Sinogen Pharmaceutical Co., Ltd · NCT05103345Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
Phase 1 · 1 location(s) · Ryan Carey · NCT06747390A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembroliz
Phase 1/Phase 2 · 9 location(s) · ImmVira Pharma Co. Ltd · NCT04370587The Clinical Efficacy and Safety of Intratumoral Injection of Chemotherapy for Advanced Solid Tumors
NA · 1 location(s) · Wuxi People's Hospital · NCT06430515Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Phase 1 · 1 location(s) · VLP Therapeutics · NCT06736379Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic H
Phase 1 · 1 location(s) · West China Hospital · NCT07625423A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Phase 1 · 17 location(s) · Aura Biosciences · NCT05483868Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pemb
Phase 1/Phase 2 · 7 location(s) · Strand Therapeutics Inc. · NCT06249048Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Witho
Phase 3 · 1 location(s) · Zhou Chengzhi · NCT06607796A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas
Phase 1 · 1 location(s) · GONGCHU Biotechnology Co., Ltd · NCT06660056A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Phase 1 · 1 location(s) · GONGCHU Biotechnology Co., Ltd · NCT06508307OH2 Injection in Combination With BS006 Injection for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Binhui Biopharmaceutical Co., Ltd. · NCT07382531Intratumoral N17350 in Advanced Solid Tumors
Phase 1/Phase 2 · 8 location(s) · Onchilles Pharma Inc · NCT07339176Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · 9 location(s) · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Phase 1/Phase 2 · 4 location(s) · GeneMedicine Co., Ltd. · NCT06265025Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Phase 1 · 5 location(s) · Ankyra Therapeutics, Inc · NCT06171750A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors
Phase 1 · 4 location(s) · Beyond Air Inc. · NCT05351502A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06347705DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
Phase 1 · 1 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT05504707Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition Af
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT03942328A Study of the Safety and Efficacy of the Intravenous and Intratumoral Injection of OVV-01 in Patients With Advanced Sol
Phase 1 · 1 location(s) · Joint Biosciences Ltd. · NCT07648472Lerapolturev (PVSRIPO) in GBM
Phase 2 · 1 location(s) · Darell Bigner · NCT06177964Study of PAT in Patients With Solid Tumor Cancers
Phase 1 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT05338658A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patie
EARLY_Phase 1 · 1 location(s) · Pure Biologics S.A. · NCT06700070
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.